Pain is a complex medical condition, which not only affects physical but also mental well-being of an individual. It is caused due to trauma or tissue damage, and its intensity varies from person to person. Pain control medications help to alleviate pain through various pathways in patient’s body. There are various types of medicines available …
Tag Archives: Pain Management Drugs Market
Pain Management Drugs Market Expected to Reach $91,649.16 million by 2027
Pain management drugs market was valued at $71,431.85 million in 2019, and is projected to reach $91,649.16 million by 2027, registering a CAGR of 3.8% from 2020 to 2027. Pain is a complex medical condition, which not only affects physical but also mental well-being of an individual. It is caused due to trauma or tissue …
Continue reading “Pain Management Drugs Market Expected to Reach $91,649.16 million by 2027”
Pain Management Drugs Market Increased Research Activities Boost Demand Opportunities 2030
The global pain management drugs market was valued at $71,431.85 million in 2019, and is projected to reach $91,649.16 million by 2027, registering a CAGR of 3.8% from 2020 to 2027. 𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 : The report provides some of the key players operating in the market include Abbott Laboratories Novartis AG, Eli Lilly …
Pain Management Drugs Market to Reach $1.04 Bn by 2027 | Eli Lilly & Company, Abbott Laboratories, Purdue Pharma L.P., Pfizer, Inc., Mylan NV.
Surge in incidences of chronic diseases, supportive regulatory scenario, and rise in aging population drive the growth of the gulf pain management drugs market. However, availability of alternative therapies, drug exploitation, and patent expiration of prescription drugs hinder the market growth. On the other hand, advancements in drug development create new opportunities in the coming …